Hainan Huitong Biopharmaceutical Technology

Hainan Huitong Biopharmaceutical Technology is a Chinese biotechnology company specializing in the development and industrialization of recombinant humanized collagen. Headquartered in Haikou, the company utilizes a proprietary yeast-based expression platform to produce high-purity collagen proteins that precisely match human genetic sequences, eliminating the risks of immunogenicity and viral contamination associated with animal-derived products. Its primary product line, the HT series, includes recombinant type III and type I collagens designed for applications in medical aesthetics, wound management, and gynecological health. Hainan Huitong operates a large-scale GMP-compliant manufacturing facility and maintains strategic research collaborations with the Institute of Microbiology of the Chinese Academy of Sciences. The company's lead program, HT-101, is widely used in clinical settings for skin barrier repair and the treatment of atrophic vaginitis.